The effect of adropin on lipid and glucose metabolism in rats with hyperlipidemia.

Abstract

Adropin may ameliorate lipid metabolism, reduce insulin resistance, and inhibit hepatocytes inflammation. Thus, adropin had significant therapeutic benefits and could be suggested as a potential candidate agent against hyperlipidemia.